Cargando…

Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older

BACKGROUND: There is limited information on short- and long-term effects of venous thromboembolism (VTE) on health-related quality of life (HRQoL) in the elderly. OBJECTIVES: To assess change in generic HRQoL and disease-specific HRQoL in patients 1 year after the VTE. METHODS: The Age and Thrombosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huijie, Klok, Frederikus A., Rosendaal, Frits R., Cushman, Mary, van Hylckama Vlieg, Astrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439441/ https://www.ncbi.nlm.nih.gov/pubmed/37601012 http://dx.doi.org/10.1016/j.rpth.2023.102144

Ejemplares similares

Association between cardiovascular risk factors and venous thromboembolism in the elderly
por: Wang, Huijie, et al.
Publicado: (2022)

Association of Remote History of Venous Thrombosis With Risk of Venous Thrombosis After Age 70 Years
por: Wang, Huijie, et al.
Publicado: (2022)

D‐dimer, thrombin generation, and risk of a first venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2021)

Procoagulant factor levels and risk of venous thrombosis in the elderly
por: Wang, Huijie, et al.
Publicado: (2020)

Whole exome sequencing in thrombophilic pedigrees to identify genetic risk factors for venous thromboembolism
por: Cunha, Marisa L. R., et al.
Publicado: (2017)

Endogenous sex hormones and risk of venous thromboembolism in young women
por: Scheres, Luuk J. J., et al.
Publicado: (2019)

Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and Predictors
por: Flinterman, Linda E., et al.
Publicado: (2012)

FFP2-mondmasker of chirurgisch mondkapje bij COVID-19
por: van Hylckama Vlieg, Astrid, et al.
Publicado: (2020)

Sex‐specific aspects of venous thromboembolism: What is new and what is next?
por: Scheres, Luuk J. J., et al.
Publicado: (2022)

Agreement of aptamer proteomics with standard methods for measuring venous thrombosis biomarkers
por: Faquih, Tariq, et al.
Publicado: (2021)

The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk
por: Khialani, Deeksha, et al.
Publicado: (2020)

Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)
por: Timp, Jasmijn F., et al.
Publicado: (2021)

Glucose levels and diabetes are not associated with the risk of venous thrombosis: results from the MEGA case‐control study
por: Li‐Gao, Ruifang, et al.
Publicado: (2018)

Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial
por: Orsi, Fernanda A., et al.
Publicado: (2019)

The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)

Statin use and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
por: Brækkan, Sigrid K., et al.
Publicado: (2017)

Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
por: Stegeman, Bernardine H, et al.
Publicado: (2013)

Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case–Control Studies
por: Nemeth, Banne, et al.
Publicado: (2015)

Risk and Risk Factors Associated With Recurrent Venous Thromboembolism Following Surgery in Patients With History of Venous Thromboembolism
por: Nemeth, Banne, et al.
Publicado: (2019)

Association of ABO blood groups with venous thrombosis recurrence in middle-aged patients: insights from a weighted Cox analysis dedicated to ambispective design
por: Munsch, Gaëlle, et al.
Publicado: (2023)

A prospective study of migraine history and venous thromboembolism in older adults
por: Folsom, Aaron R., et al.
Publicado: (2019)

Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations
por: Nab, Linda, et al.
Publicado: (2022)

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study
por: van Hylckama Vlieg, A, et al.
Publicado: (2009)

Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice
por: Hendriks, Stephan V., et al.
Publicado: (2020)

Glucocorticoid use and risk of first and recurrent venous thromboembolism: self‐controlled case‐series and cohort study
por: Orsi, Fernanda A., et al.
Publicado: (2021)

COVID-19 vaccination and venous thromboembolism risk in older veterans
por: Elkin, Peter L., et al.
Publicado: (2023)

Hematocrit and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2020)

Response: Patient and caregiver engagement in venous thromboembolism research
por: Barnes, Geoffrey D., et al.
Publicado: (2020)

Risk of recurrence in women with venous thromboembolism related to estrogen‐containing contraceptives: Systematic review and meta‐analysis
por: Wiegers, Hanke M. G., et al.
Publicado: (2022)

Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer
por: Anijs, Rayna J. S., et al.
Publicado: (2022)

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
por: Cannegieter, Suzanne C., et al.
Publicado: (2020)

Comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Klok, Frederikus A., et al.
Publicado: (2019)

The risk of recurrent venous thromboembolism after discontinuation of anticoagulant therapy in patients with cancer-associated thrombosis: a systematic review and meta-analysis
por: van Hylckama Vlieg, Marte A.M., et al.
Publicado: (2023)

Exploring Opportunities for Primary Prevention of Unprovoked Venous Thromboembolism: Ready for Prime Time?
por: Folsom, Aaron R., et al.
Publicado: (2020)

Long‐Term Association of Venous Thromboembolism With Frailty, Physical Functioning, and Quality of Life: The Atherosclerosis Risk in Communities Study
por: Lutsey, Pamela L., et al.
Publicado: (2020)

Anticoagulant Preferences and Concerns among Venous Thromboembolism Patients
por: Lutsey, Pamela L., et al.
Publicado: (2018)

Statins and Venous Thrombosis: A Story Too Good to Be True?
por: Rosendaal, Frits R.
Publicado: (2012)

Resting heart rate and incidence of venous thromboembolism
por: Folsom, Aaron R., et al.
Publicado: (2019)

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
por: Paulsen, Benedikte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o44732dr5pf4j49jf2v4rlkvvh